Oplos Medicare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.00 M
- Company Age 15 Year, 14 Days
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 3.40 Cr
- Revenue Growth 53.98%
- Profit Growth 12.84%
- Ebitda 69.55%
- Net Worth 4.06%
- Total Assets 14.24%
About Oplos Medicare Pharmaceuticals
Oplos Medicare Pharmaceuticals Private Limited (OMPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 February 2010 and has a history of 15 years. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹3.40 Cr.
Vaibhav Vohra and Arpit Vohra serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100DL2010PTC198803
- Company No.
198803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Feb 2010
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Oplos Medicare Pharmaceuticals Private Limited offer?
Oplos Medicare Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Oplos Medicare Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaibhav Vohra  | Whole-Time Director | 08-Feb-2010 | Current |
| Arpit Vohra | Whole-Time Director | 08-Feb-2010 | Current |
Financial Performance of Oplos Medicare Pharmaceuticals.
Oplos Medicare Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 53.98% increase. The company also saw a substantial improvement in profitability, with a 12.84% increase in profit. The company's net worth moved up by a moderate rise of 4.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oplos Medicare Pharmaceuticals?
In 2019, Oplos Medicare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pureca Laboratories Private LimitedVaibhav Vohra and Arpit Vohra are mutual person
- Dinkum Biological Private Limited
Arpit Vohra is a mutual person
Charges (Loans)
₹3.40 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.40 Cr
- Punjab National Bank : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2017 | Others | ₹2.40 Cr | Open |
| 19 May 2011 | Punjab National Bank | ₹1.00 Cr | Open |
How Many Employees Work at Oplos Medicare Pharmaceuticals?
Unlock and access historical data on people associated with Oplos Medicare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oplos Medicare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oplos Medicare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
